Feedback / Questions
darbepoetin alfa (NuPIAO) - 3SBio
3SBio: Interim Results 2016 Investor Conference Call
(3SBio)
-
Aug 28, 2016 -
Anticipated initiation of P2 trial in anemia associated with CKD in early 2017
Anticipated new P2 trial
•
Biosimilar
http://www.3sbio.com/images/stories/PDF/3SBio_2016_Interim_Results_Company_Presentation_Material_EN_Final.pdf
Aug 28, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious